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Abstract
Background: Previous research has mostly focused on the hormonal, behavioral and neural correlates of maternal
caregiving. We present a randomized, double-blind, placebo-controlled within-subject design to examine the
effects of intranasal administration of oxytocin and vasopressin on parenting behavior and the neural and
behavioral responses to infant cry sounds and infant threat. In addition, we will test whether effects of oxytocin and
vasopressin administration are moderated by fathers’ early childhood experiences.
Methods: Fifty-five first-time fathers of a child between two and seven months old will participate in three
experimental sessions with intervening periods of one to two weeks. Participants self-administer oxytocin,
vasopressin or a placebo. Infant-father interactions and protective parenting responses are observed during play.
Functional Magnetic Resonance Imaging (fMRI) is used to examine the neural processing of infant cry sounds and
infant threat. A handgrip dynamometer is used to measure use of handgrip force when listening to infant cry
sounds. Participants report on their childhood experiences of parental love-withdrawal and abuse and neglect.
Discussion: The results of this study will provide important insights into the hormonal, behavioral and neural
correlates of fathers’ parenting behavior during the early phase of fatherhood.
Trial registration: Dutch Trial Register: NTR (ID: NL8124); Date registered: October 30, 2019.
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Background
Parenting behavior in non-human mammals is influ-
enced by endocrine systems [1]. Hormonal processes are
also implicated in human mothering and fathering be-
haviors [2]. Several correlational studies in humans have
shown associations between oxytocin and vasopressin
levels and parent-child interactions [3–5]. Moreover,
experimental studies with intranasal administration of
oxytocin and vasopressin have shown effects on human
parenting behavior and neural responses to infant signals
[6–11]. Whereas most previous research has focused on
the hormonal, behavioral and neural correlates of mater-
nal caregiving, the present study will examine the hor-
monal, behavioral, and neural dynamics of paternal
behavior in first-time fathers during a specific phase of
fatherhood: between 2 and 7months after the baby has
been born. In this protocol, we present a randomized,
double-blind, placebo-controlled within-subject trial to
examine the effects of intranasal administration of oxy-
tocin and vasopressin on parenting behavior and the
neural and behavioral responses to infant signals. In
addition, we will examine whether effects of oxytocin
and vasopressin are moderated by fathers’ early child-
hood experiences.
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Oxytocin and vasopressin in infant-father interactions
Oxytocin and vasopressin are key hormones involved in so-
cial and affiliative processes, including human parenting be-
haviors [2]. Oxytocin and vasopressin have been associated
with the expression of paternal behavior [3–5]. In the first
months of parenthood, oxytocin levels appear to be similar
in mothers and fathers, although they seem associated with
different interaction styles. Infant-mother interactions char-
acterized by high levels of affectionate touch were associated
with an increase in oxytocin levels in mothers, whereas
infant-father interactions characterized by high levels of
stimulatory contact were associated with an increase in oxy-
tocin levels in fathers [5]. Experimental studies showed that
fathers with typically developing children and fathers of chil-
dren with autism spectrum disorder were more stimulating
of their child’s exploration and autonomy, and showed less
hostility after receiving intranasal oxytocin administration
compared to the placebo condition [7, 8].
Finally, experimental evidence showed that administra-
tion of vasopressin increased expectant fathers’ interest
in direct care for children compared to the control
group [6]. In addition, in a large sample of 119 fathers
with 4 to 6-month-old infants, higher vasopressin levels
were correlated with more stimulatory contact [3].
Oxytocin and vasopressin in paternal responses to infant
signals
Research has further shown that oxytocin and vasopres-
sin affect neural and behavior responses to infant signals
[4, 9, 10, 12–14]. For example, a small functional mag-
netic resonance imaging (fMRI) study including fathers
of 4- to 6-month-old infants reported a negative associ-
ation between fathers’ endogenous vasopressin levels
and activations in the inferior gyrus and insula when
watching their own infant play, suggesting that lower
vasopressin levels enhances social-cognitive and em-
pathic responses, although replication of these findings
in larger samples is needed [4].
However, most research examining the effects of oxyto-
cin and vasopressin on neural and behavior responses to
infant signals has been conducted in samples of women or
mothers. For example, a double-blind experimental study
including a sample of 42 nulliparous women showed that
they used less excessive handgrip force when listening to
infant cry sounds after receiving intranasal oxytocin ad-
ministration compared to women in the control group, but
this result was only found for women who had no or few
childhood experiences of harsh discipline [13], and for nul-
liparous women with insecure attachment representations
[10]. Reduced handgrip force after oxytocin administration
may represent a more sensitive caregiving response to a
crying infant, although this response seems to be
dependent on individual characteristics and experiences. A
speculative explanation for this dependency may be that
individual characteristics and experiences result in epigen-
etic changes at the oxytonergic receptor level, which may
in turn lead to decreased sensitivity for the effects of intra-
nasal administration of oxytocin [15].
On a neural level and in the same sample of Bakermans
et al. [13], nulliparous women in the oxytocin condition
showed less neural activation in the amygdala and in-
creased neural activation in the insula and inferior frontal
gyrus when listening to infant cry sounds as compared to
women in the placebo condition [9]. This pattern of
neural activation may suggest that oxytocin reduces anx-
iety and aversion and enhances empathic understanding
towards the distressed infant [9].
Interestingly, an fMRI study in a sample of 15 fathers
of children aged between 1 and 2 years reported that
oxytocin administration did not reduce neural activation
in the amygdala nor affected activation in other brain
areas when fathers listened to infant cry sounds [14].
Oxytocin administration enhanced neural responses
when father’s viewed pictures of their own children in
the caudate nucleus, dorsal anterior cingulate and visual
cortex, suggesting enhanced activation in the reward-
related circuities of the brain when fathers view pictures
of their own child [14]. Although findings of Li et al.
[14], were based on a small sample and further investiga-
tion with a larger sample is needed, it should also be
noted that differences in neural activation in response to
infant cry sounds may emerge as a result of sex-specific
neural adaptations following parenthood [16].
In contrast to oxytocin administration, it is less well
known how vasopressin administration affects behavioral
responses to infant signals and whether effects are
dependent on individual characteristics and experiences.
A study using a within-subject design showed that vaso-
pressin administration enhanced the use of excessive force
in a sample of 25 expectant fathers while viewing a picture
of an unfamiliar infant compared to viewing a morphed
picture of the expectant father’s own infant, while reversed
results were found in the placebo condition [12]. It was
suggested that vasopressin administration may enhance
the recognition of related offspring, affecting expectant fa-
thers’ behavioral responses. The use of increased handgrip
force to an unknown infant (versus own infant) might be
explained by enhanced protective parenting in favor of the
own child. No significant correlations were found between
expectant fathers’ average handgrip force and expectant
fathers’ experiences of caregiving during their childhood.
The study did not examine whether expectant fathers’
caregiving experiences during childhood moderated the
relation between vasopressin administration and use of
handgrip force [12].
The effects of vasopressin administration on neural re-
sponses to infant cry stimuli have also been examined.
In the same sample of Alyousefi-van Dijk et al. [12],
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intranasal vasopressin administration increased neural
activation in response to infant cry sounds in the anter-
ior cingulate cortex, paracingulate gyrus, and supple-
mental motor area, suggesting increased empathy and
motivation to terminate the infants’ crying [11]. This ef-
fect was stronger in expectant fathers who experienced
lower levels of parental love-withdrawal during their
childhood. Parental love-withdrawal is described as a
disciplinary strategy in which the parent withholds love
and affection when the child misbehaves or fails at a task
[17]. However, in another study it was found that vaso-
pressin administration did not affect the neural process-
ing of infant cry stimuli in fathers of 1–2-year-old
children [14].
A meta-analysis including 350 participants from 14
studies [18], largely confirmed and also extended find-
ings of previous research describing the neural circuits
involved in infant cry perception [19, 20]. Results of the
meta-analysis showed that the auditory system, the tha-
lamocingulate circuit, the dorsal anterior insula, the pre-
supplementary motor area and dorsomedial prefrontal
cortex, the inferior frontal gyrus and structures related
to motoric processing were involved in infant cry per-
ception. Neural activation in response to infant crying
was moderated by parenthood such that parents showed
more activation in the bilateral auditory cortex, posterior
insula, pre- and postcentral gyrus and right putamen
compared to non-parents, while non-parents showed
more neural activation in the right caudate nucleus than
parents [18].
Oxytocin and vasopressin in protective parenting
Finally, oxytocin and vasopressin levels may be related
to protective parenting behaviors. Animal studies have
shown evidence for the involvement of hormonal
process in the protection of offspring. For example, oxy-
tocin release in the brain of rats was positively associated
with maternal offence attacks towards an intruder placed
into the cage [21]. Moreover, administration of synthetic
oxytocin and infusion of an oxytocin receptor antagonist
resulted in, respectively, an increase and decrease in
maternal aggression towards a cage intruder. Finally,
binding of oxytocin to receptors in the lateral septum
was positively related with a peak in maternal aggressive
behaviors in rats [22]. In monogamous male prairie
voles, vasopressin injections increased and vasopressin
antagonists terminated aggressive territorial behaviors
towards intruders [23]. This increase in territorial pro-
tection, affected by higher vasopressin levels, supports
the provision of a safe environment and facilitation of
partner and offspring protection. These results show that
in non-human mammals oxytocin and vasopressin are
involved in the expression of aggressive behaviors in
situations of threat, which is in line with results of ex-
perimental studies conducted in humans.
In a double-blind between-subject design in which
men self-administered oxytocin or a placebo, oxytocin
increased in-group trust and cooperation but at the
same time increased defense aggression toward compet-
ing out-groups [24]. In another double-blind between-
subject study in men, oxytocin administration intensified
the emotional modulation of aversive social stimuli in
comparison to placebo [25]. Furthermore, a study on the
relation between oxytocin administration and protective
parenting, conducted in 16 mothers with depression,
showed that after oxytocin administration, mothers with
a depression showed increased physically and verbally
protective behaviors when confronted with a socially in-
trusive stranger [26].
Research on vasopressin administration in humans im-
plicates a link between vasopressin and male aggressive
behavior. In a double-blind between-subject study, admin-
istration of vasopressin in healthy men enhanced electro-
myography activity of the left corrugator supercilii in
response to viewing neutral facial expressions, resulting in
similar magnitudes of activation when viewing angry and
neutral facial expressions [27]. It was speculated that
administration of vasopressin may stimulate aggressive
behaviors in males by biasing them to respond to neutral
facial stimuli as if they were threatening.
The neural underpinnings of paternal protection have
received little attention. An fMRI study (with no focus
on hormonal effects) in 21 fathers explored pre- and
postnatal neural activation in response to viewing infants
in situations of threat and reported increased brain acti-
vation for infant threatening versus neutral situations in
the amygdala and various cortical and subcortical re-
gions in pre- and postnatal fatherhood [28]. The amyg-
dala has been consistently associated with the detection
of salience and threat [29, 30], and may play a pivotal
role in protective parenting behavior. Results further
indicated that neural responses to infant threat were as-
sociated with protective paternal behavior in everyday
life [28]. These findings are the basis for a better under-
standing of the neural correlates of protective paternal
behavior. It has not yet been examined how oxytocin
and vasopressin administration affect the neural process-
ing of threat to the infant.
Current study
In order to shed further light on the underlying mecha-
nisms of fathers’ parenting behavior, the present study
focuses on the hormonal, behavioral and neural under-
pinnings of fatherhood. In the current study, we will
examine the effects of oxytocin and vasopressin adminis-
tration on parenting behavior and the neural and behav-
ioral responses to infant signals. We use a randomized
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double-blind within-subject design and focus on first-
time fathers in the early postnatal period with a baby is
between 2 and 7months old.
Aims and hypotheses
Our first aim is to examine how intranasal administra-
tion of oxytocin and vasopressin affects fathers’ behav-
ioral responses to infant signals. Our second aim is to
examine how intranasal administration of oxytocin and
vasopressin affects neural responses to infant cry sounds
and infant threat. Our third aim is to explore brain-
behavior associations taking into account the effects of
oxytocin and vasopressin administration. Our final aim
is to explore whether effects of oxytocin and vasopressin
administration on behavioral and neural responses to
infant cry sounds and infant threat are moderated by
fathers’ early childhood experiences. We hypothesize
that infant-father interactions in the oxytocin and vaso-
pressin condition are characterized by enhanced stimula-
tory and sensitive play and increased protective paternal
behavior as compared to the placebo condition. We fur-
ther expect that oxytocin and vasopressin administration
affect behavioral responses to infant cry sounds and
neural responses to infant cry sounds and threat to the
infant.
Methods/design
Study design
The current study will employ a randomized-double-
blind, placebo-controlled within-subject design. Fifty-five
first-time fathers of a child aged between two and seven
months old will visit our research center for three experi-
mental sessions. The experimental sessions include three
conditions: intranasal administration of [1] oxytocin [2],
vasopressin, and [3] a placebo. Participants will be ran-
domly assigned to order of administration. Participants
and researchers are blind to order of administration. The
experimental sessions will take place with intervening
periods of one to two weeks. The datasets generated and
analyzed in the current study are archived in accordance
with the University implementation of the National
Guidelines for Archiving of Academic Research. Datasets
will be made available from the senior author upon rea-
sonable request .
Participants
Recruitment
Participants will be recruited through social media,
folders and municipality records. Municipalities will
send fathers of newborn infants on our behalf invitation
letters to participate in the study. Fathers can express
their interest for participation with an attached response
card. Interested fathers will receive a letter with detailed
information about the study and inclusion criteria are
checked in a phone call. In order to be eligible for par-
ticipation, participants must meet the following inclu-
sion criteria: first-time fathers with a child between two
and seven months old, living in the same house as their
partner and baby, both parents must have parental au-
thority. Participants will be excluded from the study in
case of a history of or when currently suffering from
neurological disorders, endocrine diseases, psychiatric
disorders, cardiovascular diseases, use of psychoactive
medications, nose injuries and disorders, or magnetic
resonance imaging contraindications.
Participants will receive a financial reward that in-
creases in value (to a maximum of €130) for each session
completed: €30 after the first session, €40 after the sec-
ond session, and €50 after the third session. At the final
visit, participants will receive a small, age-appropriate
gift for the child. Participants will receive an extra €10
after the final visit if they have completed at least 80% of
the questionnaires. Travel expenses will be covered. The
partner of the father is invited to accompany the father
and infant to our research center. In the event the part-
ner is not able to join the visit, we will arrange childcare
by an experienced babysitter chosen or approved by the
parent. Any childcare costs will be covered.
Randomization
Randomization of administration is performed by an in-
dependent researcher who is not involved in the study.
Randomization is performed before the start of the in-
terventions using a computer-generated randomization
sequence. Assigned order of administration is stored in a
locked folder in accordance with the University protocol.
For a flowchart of the phases of the present randomized
control trial, see Fig. 1. At the end of each visit, partici-
pants are asked to guess their assignment of condition.
After the third visit, participants are provided with the
option to be informed about their order of assignment.
Participants who want to be informed receive their order
of assignment by mail from an independent researcher
who is not involved in the study. Researchers are not
informed and remain blind to avoid bias that may be
generated by knowledge of condition assignment.
Sample size and power
In this within-subject experiment, the sample size will be
N = 55. For vasopressin, the literature on experimental
studies with vasopressin administration is scarce, prevent-
ing the computation of a pooled effect size via meta-
analysis. Based on the literature on oxytocin administration
[7, 9, 15, 31], a medium effect size (f = 0.25) may be ex-
pected but taking into account that some publication bias
against studies with small effect sizes may exist, we choose
an expected effect size of f = 0.20. The program G*Power
3.1.9 estimates the power of specific analyses given an
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expected effect size and a sample size. For a within-
subjects, repeated measures analysis of variance with an ex-
pected medium effect size f = 0.20, a correlation of the re-
peated measures r = 0.50, an alpha level of 0.05 and age of
the child included as a continuous variable affecting the de-
grees of freedom (df), the power is >.85. The power is > .80
when N = 42. Thus, with N = 55 we will have sufficient
power even if some participants fail to complete the ses-
sions. Similarly, this suggests sufficient statistical power for
the effects of vasopressin administration.
Procedure
In this double-blind placebo-controlled within-subject
design, participants are randomly assigned to one of the
six counterbalanced orders of conditions. Participants
are instructed to self-administer oxytocin (Syntocinon®,
24 IU/ml, registered in the Netherlands as RVG 03716),
vasopressin (Vasostrict®, 20 IU/ml), or a placebo (Chlor-
butanol solution) using a nasal spray. Self-administration
takes place under supervision of a researcher. High doses
(> 60 IU) of oxytocin nasal spray may in some cases lead
to headache. Based on the single doses of 24 IU/ml used
in the present study, side effects are negligible [32, 33].
There are no risks demonstrated to be associated with
the administration of vasopressin. All experimental
medication is prepared by the hospital pharmacy of the
Amsterdam University Medical Centre, the Netherlands.
The doses administered are comparable with the doses
previously used in research examining the behavioral
and neural effects of oxytocin and vasopressin adminis-
tration [14, 34, 35].
Participants will be instructed to not consume alcohol and
abstain from excessive physical activity 24 h before assess-
ments take place and are instructed to not consume any
caffeine on the day of assessment. The first behavioral meas-
urement takes place 30min after intranasal administration
of oxytocin, vasopressin or placebo. For an overview of the
order of assessments during each session, see Table 1. Each
session takes approximately two hours to complete.
Measures
Oxytocin and vasopressin measures
A baseline saliva sample is collected prior to administra-
tion of oxytocin, vasopressin or placebo, 30 min after
Fig. 1 Consort flowchart of the phases of the randomized double-blind placebo-controlled within-subject design. The three conditions imply six
possible counterbalanced orders of assignment. All participants are randomly assigned to each of the three conditions (oxytocin, vasopressin,
placebo). OXT; Oxytocin, AVP; Vasopressin, PLC; Placebo
Table 1 Order of research assessments during each visit
1. Hormonal measures - saliva measurement
2. Intranasal administration of oxytocin, vasopressin or placebo
3. Hormonal measures – hair assessment a
4. Questionnaires
5. Hormonal measures – saliva measurement
6. Infant-parent interaction and protective parenting b
7. Neural responses to infant cry sounds
8. Neural responses to infant threat
9. Handgrip force in response to infant cry sounds
10. Hormonal measures - saliva measurement
Note. a Hair samples are only obtained during the first research visit. b
Protective parenting is only assessed during the second research visit
Witte et al. BMC Psychology            (2019) 7:81 Page 5 of 11
administration and at the end of the research visit
(approximately two hours after administration). Partici-
pants abstain from eating and drinking (only water is ap-
proved) during their visit. To measure oxytocin and
vasopressin levels, participants chew for 60 s on a cotton
swab on which saliva collects. Samples are immediately
stored in a refrigerator at − 80 degrees Celsius until la-
boratory assessment.
Infant-parent interaction and protective parenting
Infant-father interactions will be observed during a 10-
min play session. Participants are instructed to engage in
their usual routines of play. No play material is provided
during the first five minutes of the interaction. After 5
min, the researcher will hand the father a bag of toys
and the father is instructed that he can use the toys dur-
ing play. All infant-father interactions are videotaped.
Coders will be trained to code interactions for sensitive
and stimulatory play. During the second visit, after 10
min of play, fathers and infants are exposed to a short
sound fragment (the Auditory Startling Task (AST)) to
measure protective paternal behavior. The sound con-
sists of white noise (80-db) for 10 s with short breaks.
The sound can elicit a protective paternal response with-
out exposing the infant to any harm. At the end of the
sound, the researcher enters the room and apologizes
for the sound: “I am sorry; we had some technical prob-
lems and it took me a moment to get things under con-
trol. Our apologies”. The participant is debriefed about
the purpose of the sound fragment at the end of the
third session. Protective parenting is only assessed once
in order to ensure task reliability. Coders will be trained
to code paternal responses for protective parenting be-
haviors. For all coding material, intercoder reliability
(ICC) > .60 will be obtained. Monthly meetings are orga-
nized to discuss videos and regular checks will be imple-
mented to prevent coder drift.
Neural responses to infant cry sounds
To assess neural responses to infant cry sounds participants
listen to cry and scrambled control sounds (adapted from
Thijssen et al. [11]). A total of 6 cry sounds are recorded
from 6 infants (3 males, 3 females), using a TasCam DR-05
solid-state recorder with at a 44.1 kHz sampling rate and 16
bit. All sounds are recorded between 2 days and 5.5months
after birth. All cry sounds are scaled, the intensity is nor-
malized to the same mean intensity (74 Db) and sounds are
edited to last for 10 s using PRAAT software [36]. For each
cry sound, a neutral auditory control stimulus is created by
calculating the average spectral density over the entire dur-
ation of the original sound. A continuous sound of equal
duration was re-synthesized from the average spectral dens-
ity and amplitude modulated by the amplitude envelope,
extracted from the original sound. After this procedure, all
cry sounds and control sounds are intensity matched. The
control sounds are identical to the original auditory stimuli
in terms of duration, intensity, spectral content, and ampli-
tude envelope.
A large screen located at the back of the MRI bore,
viewable through a mirror mounted on the top of the
head coil, is used to display the task. Participants ran-
domly receive one of two pre-programmed semi-random
orders. The six infant cry sounds are presented three
times (18 trials). The six corresponding control sounds
are also presented three times, leading to 36 trials. The
task is programmed in E-Prime [37].
Sounds are presented for 10 s while a fixation cross
hair remained visible on the screen. Trials are separated
by an inter stimulus interval (ISI). To maximize the
power of the design, ISI is optimized using a web-based
tool called Neurodesign [38]. In each of the two pre-
programmed orders, trials are separated by an ISI of
variable length ranging from 3.5–8.0 s, with a mean ISI
of 4.5 s. Blocks of six trials are separated by rest periods
of 15 s. During the ISI and rest periods, a fixation cross
hair remains visible. For each sound, the question: “How
urgent do you find this sound?” is presented once as
white text on a black screen together with the presenta-
tion of a Likert answer scale ranging from not urgent to
very urgent. Participants use their index finger and ring
finger to slide along the answer scale and use their
middle finger to answer the question. Questions are self-
paced and presented at fixed time points, following the
1th, 2th, 13th, 14th, 25th and 26th trial. All responses
are registered using a fiber optic response box (Current
Designs, Philadelphia, PA, USA).
Neural responses to infant threat
To assess neural responses to infant threat, participants
view neutral and threatening videos while imagining that
their own infant is shown in the videos (adapted from
Van ‘t Veer et al. [28]). Prior to the first visit, partici-
pants provide a full-color digital photo of their child
with a neutral facial expression. Photographs are edited
using Adobe Photoshop CS to remove unwanted back-
ground features. Subsequently, images are masked with
a black face contour and resized to 640 × 480 pixels.
Prior to the start of the task, the picture is shown to
familiarize the participant with the edited picture of their
child. The edited picture is also used in another task in
which we examine use of handgrip force in response to
infant cry sounds.
A large screen located at the back of the MRI bore, view-
able through a mirror mounted on the top of the head coil,
is used to display the task. Videos are separated by an inter
stimulus interval (ISI). To maximize the power of the
design, ISI was optimized using a web-based tool called
Neurodesign [38]. In each of the four pre-programmed
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semi-random orders, trials are separated by an ISI of vari-
able length ranging from 3.0–8.0 s, with a mean ISI of 4.5 s.
Participants receive 1 of the 4 pre-programmed orders of
24 threating and 24 neutral videos. Order is based on study
identification number (1 assigned to order 1, 4 to order 4,
5 to order 1, etc.). Each order ensures an equal distribution
of 12 neutral and 12 threatening videos during the first half
of the task, and 12 neutral and 12 threatening videos dur-
ing the second half of the task.
Prior to the onset of the task, participants view the
edited picture of their own infant together with a written
instruction to imagine that their own infant is displayed
in the succeeding videos. This instruction together with
the edited picture of the infant is shown again after each
8 videos (i.e. 6 times in total). After a brief stimulus
interval of 250 milliseconds, the instruction screen ad-
vances to one of the four pre-programmed semi-random
order of 48 videos with a duration of 6 s each. Neutral
and threatening video are displayed twice. Videos are se-
lected out of a pool of twelve threatening videos (e.g. hot
tea is accidentally spilled on a baby, a baby stroller acci-
dentally rolls into a river, an adult loses grip of a baby
stroller that rolls off a bridge and crashes into a cyclist, a
car seat with a baby is accidently pushed down the stairs,
a baby accidentally falls off a changing table while being
changed, and a car is parked backwards and hits a baby
in a car seat which was placed on the parking lot). The
threatening videos corresponded with twelve matched
neutral videos (e.g. tea is placed on a table next to the
baby, a baby stroller does not roll into the river, an adult
on top of a bridge safely puts baby stroller on the brakes,
a baby lies on the changing table while being changed
and a car parks backwards at a safe distance from a baby
in a car seat placed on sidewalk). These videos thus con-
trast situations in which protective action is called for,
and situations which requires no protective response.
The videos (that will be made available upon request)
are filmed using a lifelike baby doll by a professional
video production team. A neutral doll represents the
baby in the videos. In order to ease the task of imagining
their own infant in the videos and to reduce any chance
of bias, the depiction of the doll’s face and the faces of
the actors is minimized.
Handgrip force in response to infant cry sounds
Participants are asked to squeeze a handgrip dynamom-
eter when listening to infant cry sounds and control
sounds (i.e., scrambled sounds, see [12]), while they sim-
ultaneously view a picture of their own or an unknown
child. The edited picture of the fathers’ own child, previ-
ously used in the fMRI task to examine neural responses,
is also used in the present task.
A total of three cry sounds are recorded from three in-
fants (2 males, 1 female). Cry sounds are recorded within
the first two days after birth, using a TasCAM DR-05
solid-state recorder with a 44.a Khz sampling rate and 16
bit. All cry sounds are scaled, the intensity is normalized
to the same mean intensity and sounds are edited using
PRAAT software [36]. For each cry sound, a neutral con-
trol sound is created by calculating the average spectral
density over the entire duration of the original sound.
After this procedure, all cry sounds and control sounds
are intensity matched. The control sounds are identical to
the original auditory stimuli in terms of duration, inten-
sity, spectral content, and amplitude envelope.
Participants are seated comfortably in front of a laptop
screen wearing headphones, while holding the handgrip
dynamometer in their dominant hand. During an unlim-
ited practice period, participants are instructed to squeeze
the handgrip dynamometer at full and half strength.
Participants can see their performances being graphically
displayed on a monitor. The monitor is directed away
from the participant when they are able to modulate their
handgrip strength. Participants have no insight into their
performances during the experimental trials of the task.
The handgrip-force task is administered with a laptop
using E-prime (Psychology Software Tools, Inc., Sharpsburg,
PA, United States). Hand squeezes intensities (in kg) are
transferred directly from the handgrip dynamometer to
AcqKnowledge software (Biopac Systems, 2004). After the
practice period, a baseline measure of handgrip strength is
obtained. To prompt the participant, the words ‘squeeze
maximally’ are displayed in the middle of the screen for 1 s,
then a fixation is shown for 3 s, and subsequently the words
‘squeeze at half strength’ are shown for 1 s. Following this
baseline measure, participants perform three trials request-
ing to squeeze at maximally and half strength in four ran-
domly presented conditions [1]: viewing an image of their
own infant while hearing scrambled control sounds [2];
viewing an image of their own infant while hearing cry
sounds [3]; viewing an image of an unknown infant while
hearing scrambled control sounds [4]; viewing an image of
an unknown infant while hearing cry sounds. In each trial
sounds and images are presented for 12 s. After 8 s partici-
pants are prompted to squeeze at maximum strength
(instruction displayed for 1 s) followed by a request for half
handgrip strength (instruction displayed for 1 s). A fixation
cross is shown for 3 s between full- and half handgrip
strength prompts.
In line with previous studies [12, 13], modulation of
handgrip strength will be calculated by dividing half-
strength squeeze intensity by full-strength squeeze inten-
sity, so that scores above 0.5 indicate the use of excessive
handgrip force when a half-strength squeeze is requested.
Early childhood experiences
To examine the moderating role of fathers’ early child-
hood experiences, fathers report on the Conflict Tactics
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Scale – Parent Child (CTS [39];), which measures expe-
rienced abuse and neglect during childhood. Participants
also complete a questionnaire measuring use of parental
love withdrawal, containing 11 items. Participants report
on 7 items of the Love Withdrawal subscale of the Chil-
dren’s Report of Parental Behavior Inventory (CRPBI
[40, 41];), from which two items were slightly adapted
for a better translation. Four items from the Parental
Discipline Questionnaire (PDQ [42];) were added to ob-
tain a more comprehensive measurement of parental
love withdrawal. The 11-item questionnaire has been
frequently used in previously research [11, 17, 43–45].
Reliability and validity of the CRPBI and its subscales
had been established [41] and see also [46].
Background variables
We included measures on various background variables to
control for confounding effects or to compare and com-
bine the present dataset with other datasets collected as
part of the Father Trials project. During each visit partici-
pants report on their quality of sleep, personal health and
hygiene (developed for the purpose of this study), and the
Positive and Negative Affect Schedule ((PANAS [47];).
After the first visit, participants complete the following
questionnaires at home: the Baby Care Questionnaire
(BCQ [48];), Daily Life (DL; developed for the purpose of
this study), Edinburgh Postnatal Depression Scale (EPDS
[49];), The Family Assessment Device (FAD [50];), Gender
Specific Orientation Questionnaire (GSOQ, developed for
the purpose of this study), Highly Sensitive Person Scale
(HSPS [51];), Parental Protection Questionnaire (PPQ; de-
veloped for the purpose of this study), Moral Identity
Questionnaire (MIQ [52];), and the Task Division ques-
tionnaire (TD; developed for the purpose of this study).
After the first visit, online questionnaires are also sent
to the partner of the participant. The partner completes
the following questionnaires at home: BCQ (developed
for the purpose of this study), FAD [50], DL (developed
for the purpose of this study), EPDS [49] and TD (devel-
oped for the purpose of this study). The ethics commit-
tee of the Leiden University Medical Center (LUMC)
approved all questionnaires. Questionnaires developed
for the purpose of this study have been previously used
in a pilot study.
Testosterone, estradiol and cortisol levels are mea-
sured to explore relations with oxytocin and vasopressin
levels. Measures of testosterone, estradiol and cortisol
are obtained prior to administration of oxytocin, vaso-
pressin or placebo, 30 min after administration and at
the end of the research visit (approximately 2 h after ad-
ministration). Participants collect at least 1.5 ml saliva by
expectorating down a straw into a test tube. Samples are
immediately stored in a refrigerator at − 80 degrees
Celsius until laboratory assessment.
Hair samples of approximately 3–5mm (diameter) and
minimally 3 cm length are cut to measure mean cortisol
and testosterone levels of the past few months (see also
[53]). Hair samples are cut around the inion of the oc-
cipital protuberance, as close to the scalp as possible.
Hair samples are taped to a paper on which it is indi-
cated which hair strands are closest to the scalp. Hair
samples are placed into tin aluminum foil packages and
stored at room temperature until laboratory assessment.
Hair color and other potential confounders in the meas-
urement of mean cortisol and testosterone levels are
taken into account using a questionnaire (see “Con-
founders in the measurement of Corticosteroids in Hair
(CoMCoH) [53]).
Statistical analyses
To examine the effects of oxytocin and vasopressin admin-
istration on parenting behavior and the behavioral and
neural responses to infant signals, statistical analyses will be
performed within the general (ized) linear mixed model
framework (GLMM). Using GLMM, we can account for
the hierarchical structure of the data (i.e., repeated mea-
surements nested within participants). Statistical analyses
will be performed using appropriate statistical software
(e.g., Statistical Package for the Social Sciences (SPSS), R or
Mplus. Statistical analyses will be performed with an alpha
level of .05 (corrected for multiple testing using appropriate
methods, for example the Benjamini-Hochberg procedure
[54]). To explore moderation by fathers’ early childhood ex-
periences, fathers’ early childhood experiences will be added
as a moderator in the proposed GLMM models.
Data management and ethics
Data will be handled confidentially. Data will be stored
in the local computers systems of the Vrije Universiteit
Amsterdam. Data is protected in accordance with the
University protocol. Personal information and data are
treated and processed conform the European Union
General Data Protection Regulation and the Dutch Act
on Implementation of the General Data Protection
Regulation. Data and hair and saliva samples are coded
using a participant numbering system. Names and other
information that can directly identify participants is
omitted. Data cannot be traced back to participants in
scientific reports and publications about the study. The
researchers, the committee that monitors the safety of
the study, the Medical Ethical Committee of the LUMC,
and the Inspection for the Healthcare have access to the
data. All persons with access to the data keep the data
confidential. Participants who have any questions or
complaints about the processing of personal information
can contact the principal investigator of the present
study, the Institutional Data Protection Officer, or de
Dutch Protection Authority.
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The research protocol (NL70143.058.19) has been
approved by the ethics committee of the LUMC. Partici-
pants provide written consent for participation and the
use and storage of data. Data and hair and saliva samples
are stored for 15 years. Both parents provide written
consent for participation of their child, and the use and
storage of data concerning their child. Participants are
informed that participation is voluntary and that they
can withdraw from the study at any time, without pro-
viding any reason and without any consequences. Con-
sent forms and all communication material have been
approved by the ethics committee of the LUMC and are
available upon request from the corresponding author.
Participants can contact an independent expert who is
available during the course of the study for questions
and advice.
There are no risks associated with the assessments
used in the study. Possible side effects of oxytocin are
negligible [32, 33]. No adverse effects have been reported
in participants undergoing fMRI at the currently used
field strengths.
Participants will be informed about the study findings
via newsletters, which are produced every six months.
Furthermore, we will disseminate findings through peer-
reviewed publications, scientific conferences, interviews,
and public lectures. Any changes in the research proto-
col are communicated to the Netherlands Trial Registry
(NTR), ethics committee of the LUMC and to BMC
Psychology. When necessary, additional consent is ob-
tained from participants. Authorships of publications
will be based on recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in
Medical Journals [55]. The trial is registered in the NTR
(Trial ID: NL8124), Date registered: October 29, 2019).
Discussion
The present study will examine the hormonal, behav-
ioral, and neural underpinnings of paternal behavior in
first-time fathers during a specific phase of fatherhood:
between two and seven months after the baby has been
born. The current study protocol presents a randomized,
double-blind, placebo-controlled within-subject trial in
which we aim to examine the effects of intranasal ad-
ministration of oxytocin and vasopressin on parenting
behavior and the neural and behavioral responses to in-
fant signals. Moreover, we will examine brain-behavior
associations, taking into account the effects of oxytocin
and vasopressin. Finally, we will examine whether behav-
ioral and neural effects are moderated by fathers’ early
childhood experiences.
Strengths and limitations
The experimental within-subject design of the study is
the most important strength of the study. A randomized,
double-blind, placebo-controlled within-subject design is
considered the gold standard in testing intervention
effects. Randomization ensures unbiased assignment of
participants to the conditions and blind assessments
eliminate (un) conscious human influence on research
outcomes. Furthermore, it is the first study examining
oxytocin and vasopressin administration in a within-
subject design including first-time fathers in the early
phase of fatherhood. Most previous research has focused
on maternal caregiving, the outcomes of this study will
provide important insights into the hormonal, behavioral
and neural correlates of fathers’ parenting behavior and
will contribute to a better and broader understanding
about fatherhood. Another strength of the study is that
effects of oxytocin and vasopressin administration are
measured on a behavioral and neural level, which will
contribute to an improved understanding of brain-
behavior associations.
Limitations of the study should also be noted. First, we
will recruit participants through municipality records.
Fathers have to express their interest in participation
with the attached response card, which may result in
selection bias. However, by recruitment via municipality
records all fathers in the general population are invited
to participate in the study and random assignment of
participants to all three conditions limits the potential
influence of selection bias on our study outcomes.
Another limitation is the inclusion of first-time fathers
during a specific phase of fatherhood: when the infant is
between two and seven months old. However, a focus
on fathers in the early postnatal period is important as
this marks a period in which men adapt and grow into
their new role of being a father. Nevertheless, the results
may not be generalizable to fathers with two or more
children and to first-time fathers with children in an
older age range.
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